The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 601–700 of 1,002
Nutrigenomics in Regulating the Expression of Genes Related to Type 2 Diabetes Mellitus
Felisbino, K., Granzotti, J. G., Bello-Santos, L., & Guiloski, I. C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.699220 · Cited by 43
Taniguchi-Fukatsu, A., Yamanaka‐Okumura, H., Naniwa-Kuroki, Y., Nishida, Y., Yamamoto, H., Taketani, Y., & Takeda, E. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004156 · Cited by 43
Sbraccia, P., D’Adamo, M., & Guglielmi, V. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01109-4 · Cited by 43
Haas, B., Schlinkert, P., Mayer, P. E., & Eckstein, N. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-43 · Cited by 43
Pathophysiology of type 2 diabetes: Rationale for different oral antidiabetic treatment strategies
Giorgino, F., Laviola, L., & Leonardini, A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.012 · Cited by 43
Li, S., Chen, W., Srinivasan, S. R., Boerwinkle, E., & Berenson, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1265 · Cited by 43
Zhu, Y., Li, A. M., Au, C. T., Kong, A. P. S., Zhang, J., Wong, C. K., Chan, J. C. N., & Wing, Y. K. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12138 · Cited by 42
Xu, W., Qadir, M. M. F., Nasteska, D., de Sa, P. M., Gorvin, C. M., Blandino-Rosano, M., Evans, C. R., Ho, T., Potapenko, E. S., Veluthakal, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112529 · Cited by 42
Serbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 42
Mathieu, C., Shankar, R. R., Lorber, D., Umpierrez, G. E., Wu, F., Xu, L., Golm, G. T., Latham, M., Kaufman, K. D., & Engel, S. S. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0105-3 · Cited by 42
Peroxisome proliferator-activated receptor translational research and clinical experience
Cheatham, W. W. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28449d · Cited by 42
Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro
Viviani, G. L., Puddu, A., Sacchi, G., Garuti, A., Storace, D., Durante, A., Monacelli, F., & Odetti, P. R. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.020 · Cited by 42
Kim, H., Choi, S., Lee, S., Lee, J., Lee, Y.-J., Kang, S. S., Chun, J., & KANG, Y. Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0131 · Cited by 42
Garcia-Campoy, A. H., Gutiérrez, R. M. P., Manriquez-Alvirde, G., & Muñiz-Ramírez, A. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s163714 · Cited by 42
Treating prediabetes: why and how should we do it?
Braga, T. G., Kraemer‐Aguiar, L. G., Docherty, N. G., & le Roux, C. W. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05897-4 · Cited by 42
Love-Osborne, K., Butler, N., Gao, D., & Zeitler, P. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00179.x · Cited by 42
Insulin resistance and β‐cell function – a clinical perspective
Matthews, D. R. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00029.x · Cited by 42
Leptin and Body Fat in Type 2 Diabetes and Monodrug Therapy
Sivitz, W. I., Wayson, S. M., Bayless, M., Larson, L. F., Sinkey, C. A., Bar, R. S., & Haynes, W. G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021193 · Cited by 42
A potential role for GPR55 in the regulation of energy homeostasis
Simcocks, A. C., O’Keefe, L., Jenkin, K. A., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.005 · Cited by 42
Mita, T., Watada, H., Nakayama, S., Michiko, A. B. E., Ogihara, T., Shimizu, T., Uchino, H., Hirose, T., & Kawamori, R. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-198 · Cited by 42
Determining the relationship between dietary carbohydrate intake and insulin resistance
McClenaghan, N. H. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005109 · Cited by 42
Kim, J. Y., Goran, M. I., Toledo‐Corral, C. M., Weigensberg, M. J., Choi, M., & Shaibi, G. Q. (2013) · Diabetes Care · doi:10.2337/dc12-1861 · Cited by 42
Shimizu, S., Hosooka, T., Matsuda, T., Asahara, S., Kimura-Koyanagi, M., Kanno, A., Bartolomé, A., Etoh, H., Fuchita, M., Teruyama, K., et al. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0039 · Cited by 42
Coronary Atherosclerosis and Alcohol Consumption
Femia, R., Natali, A., L’Abbate, A., & Ferrannini, E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222929.99098.1f · Cited by 42
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41
Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus
Timar, R. Z., Timar, B., Degeratu, D., Serafinceanu, C., & Oancea, C. I. (2014) · Journal of International Medical Research · doi:10.1177/0300060514541829 · Cited by 41
Wang, Y., Xue, J., Li, Y., Zhou, X., Qiao, S., & De-wu, H. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3383 · Cited by 41
Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz, H. E. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.10.809 · Cited by 41
Horton, E. S., Foley, J. E., Shen, S. G., & Baron, M. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003881 · Cited by 41
Weyer, C., Salbe, A. D., Lindsay, R. S., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2001) · Metabolism · doi:10.1053/meta.2001.20170 · Cited by 41
Self-citationMetabolic follow-up after long-term pancreas graft survival
Dieterle, C. D., Arbogast, H. P., Illner, W., Schmauss, S., & Landgraf, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0658 · Cited by 41
The Minimal Model of Glucose Regulation: A Biography
Bergman, R. N. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9019-8_1 · Cited by 41
Ehrmann, D. A., Breda, E., Cavaghan, M. K., Bajramovic, S., Imperial, J., TOFFOLO, G. M., Cobelli, C., & Polonsky, K. S. (2002) · Diabetologia · doi:10.1007/s00125-002-0776-y · Cited by 41
Islet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 40
Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
Scheithauer, T. P. M., Herrema, H., Yu, H., Bakker, G. J., Winkelmeijer, M., Soukhatcheva, G., Dai, D. L., Ma, C., Havik, S. R., Balvers, M., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111951 · Cited by 40
Validation of Insulin Sensitivity and Secretion Indices Derived from the Liquid Meal Tolerance Test
Maki, K. C., Kelley, K., Lawless, A. L., Hubacher, R., Schild, A. L., Dicklin, M. R., & Rains, T. M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0240 · Cited by 40
Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose
Dagogo-Jack, S. E., Askari, H., & Tykodi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1348 · Cited by 40
Choukem, S. P., Sobngwi, E., Fetita, L.-S., Boudou, P., de Kerviler, É., Boirie, Y., Hainault, I., Vexiau, P., Mauvais‐Jarvis, F., Calvo, F. M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0914 · Cited by 40
Liu, J., Liu, J., Li, P., Xie, X., Guo, Q., Tian, L., Ma, X., Zhang, J., Liu, J., & Gao, J. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.017 · Cited by 40
Bonora, E. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01441.x · Cited by 40
Early endocrine and molecular changes in metabolic syndrome models
Larqué, C., Velasco, M., Navarro‐Tableros, V., Duhne, M., Aguirre, J., Gutiérrez‐Reyes, G., Moreno, J., Robles‐Díaz, G., Hong, E., & Hiriart, M. (2011) · IUBMB Life · doi:10.1002/iub.544 · Cited by 40
Type 2 Diabetes and Vascular Complications: A pathophysiologic view
Ahmed, K. A., Muniandy, S., & Ismail, I. S. (2010) · Biomedical Research-tokyo · Cited by 40
Preclinical developments in type 2 diabetes
Lenhard, J. M., & Gottschalk, W. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00092-3 · Cited by 40
Fonseca, V. A., Grunberger, G., Gupta, S., Shen, S. G., & Foley, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1685 · Cited by 40
Wanders, A. J., Alssema, M., de Koning, E. J. P., le Cessie, S., de Vries, J. H. M., Zock, P. L., Rosendaal, F. R., den Heijer, M., & de Mutsert, R. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.204 · Cited by 39
Kim, M. K., Reaven, G. M., & Kim, S. H. (2016) · Obesity · doi:10.1002/oby.21699 · Cited by 39
Regulation of glucose metabolism in nondiabetic, metabolically obese normal-weight Asians
Ding, C., Chan, Z., Chooi, Y. C., Choo, J., Sadananthan, S. A., Chang, A., Sasikala, S., Michael, N., Velan, S. S., & Magkos, F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00382.2017 · Cited by 39
Qu, H., Qiu, Y., Wang, Y., Liao, Y., Zheng, Y., & Zheng, H. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.02.003 · Cited by 39
The Association of Statin Therapy with Incident Diabetes: Evidence, Mechanisms, and Recommendations
Agarwala, A., Kulkarni, S., & Maddox, T. M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0995-6 · Cited by 39
Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: A scoping review
Shlobin, N. A., & Sander, J. W. A. S. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107043 · Cited by 39
Roles of mTOR in the Regulation of Pancreatic β-Cell Mass and Insulin Secretion
Asahara, S., Inoue, H., Watanabe, H., & Kido, Y. (2022) · Biomolecules · doi:10.3390/biom12050614 · Cited by 39
Orlistat in the prevention of diabetes in the obese patient
Mancini, M. C. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6808 · Cited by 39
Physiopathologie du diabète de type 2
Guillausseau, P.-J., & Laloi-Michelin, M. (2003) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(03)00244-3 · Cited by 39
Park, J., Shim, H. M., Na, A., Bae, K., Bae, J., Im, S., Cho, H., & Song, D. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12106 · Cited by 39
Bunprajun, T., Henriksen, T. I., Schéele, C., Pedersen, B. K., & Green, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066628 · Cited by 39
Watanabe, Y., Nakayama, K., Taniuchi, N., Horai, Y., Kuriyama, C., Ueta, K., Arakawa, K., Senbonmatsu, T., & Shiotani, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116851 · Cited by 39
Larsen, M. O., Juhl, C. B., Pørksen, N. K., Gotfredsen, C. F., Carr, R. D., Ribel, U., Wilken, M., & Rolin, B. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00352.2004 · Cited by 39
Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC): design and methods.
Dagogo-Jack, S. E., Edeoga, C., Nyenwe, E. A., Chapp-Jumbo, E. N., & Wan, J. Y. (2011) · PubMed · Cited by 39
Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes?
Sesti, G. (2002) · Annals of Medicine · doi:10.1080/078538902321012397 · Cited by 39
Oral antidiabetic agents: 2004
Lebovitz, H. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.05.002 · Cited by 39
Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans
Shah, M. H., Piaggi, P., Looker, H. C., Paddock, E., Krakoff, J. A., & Chang, D. C. (2021) · Diabetologia · doi:10.1007/s00125-020-05348-5 · Cited by 38
Shih, K., & Kwok, C. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1025-y · Cited by 38
Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes
Cerf, M. E. (2013) · Endocrine · doi:10.1007/s12020-013-9917-y · Cited by 38
Rapid Deterioration of Insulin Secretion in Obese Adolescents Preceding the Onset of Type 2 Diabetes
Elder, D. A., Hornung, L. N., Herbers, P. M., Prigeon, R. L., Woo, J. G., & D’Alessio, D. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.029 · Cited by 38
Ek, J., Rose, C. S., Jensen, D. P., Glümer, C., Borch‐Johnsen, K., Jørgensen, T., Pedersen, O. B., & Hansen, T. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2159 · Cited by 38
Carpentier, A. C., Zinman, B., Leung, N. M., Giacca, A., Hanley, A. J., Harris, S. B., Hegele, R. A., & Lewis, G. F. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1485 · Cited by 38
Xiang, A. H., Trigo, E., Martinez, M., Katkhouda, N., Beale, E., Wang, X., Wu, J., Chow, T., Montgomery, C., Nayak, K. S., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1662 · Cited by 37
Sheng, C., Li, F., Lin, Z., Zhang, M., Yang, P., Bu, L., Sheng, H., Li, H., & Qu, S. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6035046 · Cited by 37
Drosophila Models to Investigate Insulin Action and Mechanisms Underlying Human Diabetes Mellitus
Inoue, Y. H., Katsube, H., & Hinami, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_13 · Cited by 38
Mechanisms and therapeutic targets in type 2 diabetes mellitus
Panunti, B. A., Jawa, A., & Fonseca, V. A. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.011 · Cited by 37
A review of nateglinide in the management of patients with type 2 diabetes.
Tentolouris, N., Voulgari, C., & Katsilambros, N. L. (2007) · PubMed Central · Cited by 37
Davies, M. J. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000200 · Cited by 37
Rich, S. S., Goodarzi, M. O., Palmer, N. D., Langefeld, C. D., Ziegler, J. T., Haffner, S. M., Bryer‐Ash, M., Norris, J. M., Taylor, K. D., Haritunians, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1373-0 · Cited by 37
The mechanisms underlying the unique pharmacodynamics of nateglinide
Hu, S., Boettcher, B. R., & Dunning, B. E. (2003) · Diabetologia · doi:10.1007/s00125-002-0935-1 · Cited by 37
Qarni, A. A. A., Joatar, F. E., Das, N. S., Awad, M., Eltayeb, M., Al-Zubair, A. G., Ali, M. E., Masaud, A. A., Shire, A. M., Gumaa, K. A., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.230 · Cited by 36
Yang, Y., Kim, J., Park, H., Lee, E., & Yoon, K. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13202 · Cited by 36
Thakar, S., Katakia, Y. T., Ramakrishnan, S. K., Thakkar, N. P., & Majumder, S. (2021) · Cells · doi:10.3390/cells10102548 · Cited by 36
Chen, S., Miki, T., Fukunaga, A., Eguchi, M., Kochi, T., Nanri, A., Kabe, I., & Mizoue, T. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.039 · Cited by 36
Nateglinide - current and future role in the treatment of patients with type 2 diabetes mellitus
Campbell, I. W. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00669.x · Cited by 36
Dagogo-Jack, S. E., Edeoga, C., Ebenibo, S., & Chapp-Jumbo, E. N. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2902 · Cited by 36
Surendran, S., & Kondapaka, S. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.039 · Cited by 36
Tenenbaum, H., Behar, S., Boyko, V., Adler, Y., Fisman, E. Z., Tanné, D., Lapidot, M., Schwammenthal, E., Feinberg, M. S., Matas, Z., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.005 · Cited by 36
The Management of Type 2 Diabetic Patients with Hypoglycaemic Agents
Tsang, M.-W. (2012) · ISRN Endocrinology · doi:10.5402/2012/478120 · Cited by 36
Role of theENPP1K121Q Polymorphism in Glucose Homeostasis
Baratta, R., Rossetti, P., Prudente, S., Barbetti, F., Sudano, D., Nigro, A., Farina, M. G., Pellegrini, F., Trischitta, V., & Frittitta, L. (2008) · Diabetes · doi:10.2337/db07-1830 · Cited by 36
Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again
Shuldiner, A. R., & McLenithan, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23586 · Cited by 36
Abdul‐Ghani, M. A., Matsuda, M., Sabbah, M., Jenkinson, C. P., Richardson, D. K., Kaku, K., & DeFronzo, R. A. (2007) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.02.004 · Cited by 35
Koivula, R. W., Forgie, I. M., Kurbasic, A., Viñuela, A., Heggie, A. J., Giordano, G. N., Hansen, T. H., Hudson, M., Koopman, A. D. M., Rutters, F., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4906-1 · Cited by 35
The β-cell glucose toxicity hypothesis: Attractive but difficult to prove
Weir, G. C., Butler, P. C., & Bonner‐Weir, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154870 · Cited by 35
Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review
Am, C., Antonucci, G., Conte, M., Pumpo, M. D., Giancola, A., & Antonucci, E. (2010) · Current Diabetes Reviews · doi:10.2174/157339910791658844 · Cited by 35
Metabolic Syndrome and Progression of Atherosclerosis among Middle-aged US Adults
Fan, A. Z. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.46 · Cited by 35
The pathophysiological basis for intensive insulin replacement
Rolla, A. R. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802743 · Cited by 35
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion
Williams, R. C., Muller, Y. L., Hanson, R. L., Knowler, W. C., Mason, C. C., Bian, L., Ossowski, V., Wiedrich, K., Chen, Y. F., Marcovina, S. M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2122-8 · Cited by 35
Self-citationChung, M., KOURIDES, I. A., Canovatchel, W. J., Sutfin, T. A., Messig, M., & Chaiken, R. L. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00970002042006007 · Cited by 35
Sex Differences in Glucose and Fatty Acid Metabolism in Asians Who Are Nonobese
Chan, Z., Chooi, Y. C., Ding, C., Choo, J., Sadananthan, S. A., Michael, N., Velan, S. S., Leow, M. K., & Magkos, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01421 · Cited by 34
Hou, X., Liu, J., Song, J., Wang, C., Liang, K., Sun, Y. S., Ma, Z., Yang, W., Li, C., Zhang, X., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2016/8797316 · Cited by 35
Weight Management: Obesity to Diabetes
Franz, M. J. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0011 · Cited by 34
Alidu, H. W., Dapare, P. P. M., Quaye, L., Amidu, N., Bani, S. B., & Banyeh, M. (2023) · BioMed Research International · doi:10.1155/2023/8873226 · Cited by 34
Lewis, G. F., Carpentier, A. C., & Giacca, A. (2001) · Diabetologia · doi:10.1007/s001250100002 · Cited by 34
Wiseman, D. A., & Thurmond, D. C. (2012) · Current Diabetes Reviews · doi:10.2174/157339912800840514 · Cited by 34
Efficacy of biphasic insulin aspart in patients with type 2 diabetes
Halimi, S., Raskin, P., Liebl, A., Kawamori, R., Fulcher, G., & Gao, Y. H. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.021 · Cited by 34
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
